TAO Synergies
TAOX | NASDAQ
$1.86
-$0.24 (-11.43%)
At close: Nov 16, 2026, 4:00 PM ET
$1.90
+$0.04 (+2.15%)
After-hours:
Nov 16, 2026, 5:23 PM ET
-11.43%
(1D)No price chart data available for 1D timeframe.
Rating
47.8
Fundamentals Average
Market Sentiment Neutral
Moat None
Sector Rank #427/817 (Top 52%)
Key Statistics
Market Data
Market Cap $14.96M
1D Range
1.85 2.01
52W Range
1.85 7.58
Valuation (TTM)
PE -0.47
PB 0.87
EV/EBITDA 0.50
Valuation (NTM)
Forward PE N/A
Forward PEG 0.03
Price Target $0.00
Cash Flow
FCF Yield -41.5%
SBC Adj. FCF Yield -44.8%
SBC Impact -8.0%
Margins
Gross Margin 99.9%
Operating Margin -1085.3%
FCF Margin -803.0%
Growth (CAGR)
Revenue 3Y | 5Y 150.0% |
N/A
Dil EPS 3Y | 5Y 63.1% |
N/A
FCF 3Y | 5Y -11.1% |
N/A
Returns
ROA -78.9%
ROE -81.2%
ROIC -41.8%
Financial Health
Net Cash
$19.18M
Current Ratio 19.99
Interest Coverage 0.00
Dividends
Div Yield N/A
Payout Ratio N/A
FCF Payout Ratio N/A
Loading financial charts...
Profile
TAO Synergies Inc. operates as a biopharmaceutical company currently in the clinical development stage. It is dedicated to advancing a bryostatin-1 therapeutic platform, specifically designed to comba...
Sector Technology
Industry Software - Application
Employees 5
IPO Date Jul 2, 2025
Website www.taosynergies.com
Fiscal Year January - December
Latest News
No news articles available yet.
Add to Watchlist
Select watchlists to add or remove TAOX